Alam Kamran 4
4 · Taysha Gene Therapies, Inc. · Filed Aug 25, 2023
Insider Transaction Report
Form 4
Alam Kamran
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2023-08-24$2.33/sh−33,000$76,890→ 258,042 total
Footnotes (2)
- [F1]This sale was effected pursuant to a mandatory "sell to cover" arrangement adopted by the Reporting Person on May 26, 2023 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.185 to $2.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.